Hemofiltration for Contrast-Induced Nephropathy

This study is currently recruiting participants.

Verified by Nara Medical University, September 2005

First Received: September 7, 2005 No Changes Posted

Sponsored by:	Nara Medical University
Information provided by:	Nara Medical University
ClinicalTrials.gov Identifier:	NCT00158080

Purpose

Contrast-induced acute renal failure can be prevented with hemofiltration which is performed during cardiac catheterization

Condition	Intervention
Chronic Kidney Disease Cardiac Catheterization	Procedure: hemofiltration

MedlinePlus related topics: Kidney Failure

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Prevention, Randomized, Open Label, Placebo Control, Parallel Assignment, Efficacy Study
Official Title:	Prevention of Contrast-Induced Nephropathy by Real-Time Hemofiltration

Further study details as provided by Nara Medical University:

Primary Outcome Measures:

Prevention of contrast-induced acute renal failure, Elevation of serum creatinine

Secondary Outcome Measures:

Need for hemodialysis

Estimated Enrollment:

100

Eligibility

Ages Eligible for Study:	20 Years to 90 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Patients with serum creatinine>2.0mg/dl and/or GFR<50ml/min

Exclusion Criteria:

Emergent cardiac catheterization
Patients on chronic dialysis
Patients with HYHA>III heart failure

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00158080

Contacts

Contact: Koji Harada, MD

+81-744-22-3051 ext 3411

kzharada@naramed-u.ac.jp

Locations

Japan, Nara
First Dept of InternalMedicine, Nara Medical University	Recruiting
Kashihara, Nara, Japan, 634-8522
Contact: Koji Harada, MD +81-744-22-3051 ext 3411 kzharada@naramed-u.ac.jp

Sponsors and Collaborators

Nara Medical University

Investigators

Study Director:

Yoshihiko Saito, MD, PhD

Nara Medical University

More Information

Publications:

Kashyap AS, Anand KP, Kashyap S. Hemofiltration and the prevention of radiocontrast-agent-induced nephropathy. N Engl J Med. 2004 Feb 19;350(8):836-8; author reply 836-8. No abstract available.

Study ID Numbers:	K0001
Study First Received:	September 7, 2005
Last Updated:	September 7, 2005
ClinicalTrials.gov Identifier:	NCT00158080 History of Changes
Health Authority:	Japan: Ministry of Health, Labor and Welfare

Study placed in the following topic categories:

Renal Insufficiency
Urologic Diseases
Renal Insufficiency, Chronic

Kidney Failure, Chronic
Kidney Diseases
Kidney Failure

Additional relevant MeSH terms:

Renal Insufficiency
Urologic Diseases
Renal Insufficiency, Chronic

Kidney Failure, Chronic
Kidney Diseases
Kidney Failure

ClinicalTrials.gov processed this record on May 06, 2009